Edition:
United Kingdom

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

74.05USD
7:37pm GMT
Change (% chg)

$0.66 (+0.90%)
Prev Close
$73.39
Open
$74.16
Day's High
$74.26
Day's Low
$73.43
Volume
24,089
Avg. Vol
31,457
52-wk High
$76.98
52-wk Low
$48.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.02 -0.811
Jun '18 0.02 -0.547
Mar '18 0.03 -1.069
FY 2017 Dec '17 0.28 -0.925
Sep '17 0.43 -1.039
Jun '17 0.44 -0.945
Mar '17 0.37 -0.775
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 2 0.00 0.00 0.00 0.40
Quarter Ending Jun-19 2 0.00 0.00 0.00 0.40
Year Ending Dec-19 7 1.54 10.00 0.00 1.81
Earnings (per share)
Quarter Ending Mar-19 2 -1.02 -0.96 -1.08 --
Quarter Ending Jun-19 2 -1.07 -1.01 -1.13 --
Year Ending Dec-19 7 -3.84 -1.38 -4.83 -3.77
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta -- 1.08 0.90
Price to Sales (TTM) 367.07 49.51 6.28
Price to Book (MRQ) 7.85 10.16 5.27
Price to Tangible Book (MRQ) 9.04 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 64.55 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -60.92 130.04 9.72
Sales (TTM) vs TTM 1 Yr. Ago -53.33 47.85 5.87
Sales - 5 Yr. Growth Rate -- 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -79.01 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago -40.57 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate -- 9.25 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) 8.54 3.43 3.08
LT Debt to Equity (MRQ) 0.00 18.73 11.38
Total Debt to Equity (MRQ) 0.00 31.43 16.13
Interest Coverage (TTM) -- -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -2,898.05 -- --
EBITD - 5 Yr. Avg -- -110.23 12.87
Operating Margin (TTM) -2,920.87 -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.68 8.31
Pre-Tax Margin (TTM) -2,993.16 -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.83 8.61
Net Profit Margin (TTM) -2,990.32 -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -- -137.23 4.88
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 35,176 7,650,725 844,239,694
Net Income/Employee (TTM) -1,051,866 652,578 100,064,161
Receivable Turnover (TTM) 7.19 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.02 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -73.87 6.45 11.08
Return on Assets - 5 Yr. Avg. -- 5.52 12.21
Return on Investment (TTM) -83.31 8.99 14.48
Return on Investment - 5 Yr. Avg. -- 6.85 15.88
Return on Equity (TTM) -83.31 10.13 15.99
Return on Equity - 5 Yr. Avg. -- 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -43.26 -39.12 --
EPS (TTM) % -86.17 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ascendis Pharma A/S

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 25.98 21.63 99 99
13 Week 27.10 20.91 99 95
26 Week 30.62 20.69 99 98
52 Week 78.77 51.52 99 72
YTD 76.83 55.29 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 93.71%
# of Holders: 115
Total Shares Held: 39,388,765
3 Mo. Net Change: -965,963
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 3
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.